Literature DB >> 19096995

In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens.

Judith M Rollinger1, Daniela Schuster, Birgit Danzl, Stefan Schwaiger, Patrick Markt, Michaela Schmidtke, Jürg Gertsch, Stefan Raduner, Gerhard Wolber, Thierry Langer, Hermann Stuppner.   

Abstract

The identification of targets whose interaction is likely to result in the successful treatment of a disease is of growing interest for natural product scientists. In the current study we performed an exemplary application of a virtual parallel screening approach to identify potential targets for 16 secondary metabolites isolated and identified from the aerial parts of the medicinal plant RUTA GRAVEOLENS L. Low energy conformers of the isolated constituents were simultaneously screened against a set of 2208 pharmacophore models generated in-house for the IN SILICO prediction of putative biological targets, i. e., target fishing. Based on the predicted ligand-target interactions, we focused on three biological targets, namely acetylcholinesterase (AChE), the human rhinovirus (HRV) coat protein and the cannabinoid receptor type-2 (CB (2)). For a critical evaluation of the applied parallel screening approach, virtual hits and non-hits were assayed on the respective targets. For AChE the highest scoring virtual hit, arborinine, showed the best inhibitory IN VITRO activity on AChE (IC (50) 34.7 muM). Determination of the anti-HRV-2 effect revealed 6,7,8-trimethoxycoumarin and arborinine to be the most active antiviral constituents with IC (50) values of 11.98 muM and 3.19 muM, respectively. Of these, arborinine was predicted virtually. Of all the molecules subjected to parallel screening, one virtual CB (2) ligand was obtained, i. e., rutamarin. Interestingly, in experimental studies only this compound showed a selective activity to the CB (2) receptor ( Ki of 7.4 muM) by using a radioligand displacement assay. The applied parallel screening paradigm with constituents of R. GRAVEOLENS on three different proteins has shown promise as an IN SILICO tool for rational target fishing and pharmacological profiling of extracts and single chemical entities in natural product research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19096995      PMCID: PMC3525952          DOI: 10.1055/s-0028-1088397

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  31 in total

Review 1.  In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

Review 2.  Enhancing drug discovery through in silico screening: strategies to increase true positives retrieval rates.

Authors:  J Kirchmair; S Distinto; D Schuster; G Spitzer; T Langer; G Wolber
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products.

Authors:  K Ingkaninan; C M de Best; R van der Heijden; A J Hofte; B Karabatak; H Irth; U R Tjaden; J van der Greef; R Verpoorte
Journal:  J Chromatogr A       Date:  2000-03-03       Impact factor: 4.759

4.  A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1.

Authors:  M Schmidtke; U Schnittler; B Jahn; H Dahse; A Stelzner
Journal:  J Virol Methods       Date:  2001-06       Impact factor: 2.014

5.  Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow.

Authors:  Patrick Markt; Clemens Feldmann; Judith Maria Rollinger; Stefan Raduner; Daniela Schuster; Johannes Kirchmair; Simona Distinto; Gudrun Maria Spitzer; Gerhard Wolber; Christian Laggner; Karl-Heinz Altmann; Thierry Langer; Jürg Gertsch
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

6.  Beta-caryophyllene is a dietary cannabinoid.

Authors:  Jürg Gertsch; Marco Leonti; Stefan Raduner; Ildiko Racz; Jian-Zhong Chen; Xiang-Qun Xie; Karl-Heinz Altmann; Meliha Karsak; Andreas Zimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-23       Impact factor: 11.205

Review 7.  Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.

Authors:  Norman R Relkin
Journal:  Expert Rev Neurother       Date:  2007-06       Impact factor: 4.618

8.  Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.

Authors:  Judith M Rollinger; Theodora M Steindl; Daniela Schuster; Johannes Kirchmair; Kathrin Anrain; Ernst P Ellmerer; Thierry Langer; Hermann Stuppner; Peter Wutzler; Michaela Schmidtke
Journal:  J Med Chem       Date:  2008-02-05       Impact factor: 7.446

Review 9.  Acetylcholinesterase inhibitors from plants.

Authors:  Pulok K Mukherjee; Venkatesan Kumar; Mainak Mal; Peter J Houghton
Journal:  Phytomedicine       Date:  2007-03-07       Impact factor: 5.340

Review 10.  In silico pharmacology for drug discovery: applications to targets and beyond.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

View more
  29 in total

Review 1.  Phytocannabinoids beyond the Cannabis plant - do they exist?

Authors:  Jürg Gertsch; Roger G Pertwee; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Counting on natural products for drug design.

Authors:  Tiago Rodrigues; Daniel Reker; Petra Schneider; Gisbert Schneider
Journal:  Nat Chem       Date:  2016-04-25       Impact factor: 24.427

Review 3.  Modern natural products drug discovery and its relevance to biodiversity conservation.

Authors:  David G I Kingston
Journal:  J Nat Prod       Date:  2010-12-07       Impact factor: 4.050

Review 4.  The chemical basis of pharmacology.

Authors:  Michael J Keiser; John J Irwin; Brian K Shoichet
Journal:  Biochemistry       Date:  2010-11-12       Impact factor: 3.162

Review 5.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

6.  Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine.

Authors:  Birgit Waltenberger; Daniela Schuster; Sompol Paramapojn; Wandee Gritsanapan; Gerhard Wolber; Judith M Rollinger; Hermann Stuppner
Journal:  Phytomedicine       Date:  2010-09-20       Impact factor: 5.340

Review 7.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

8.  Secondary metabolites from the stem of Ravenia spectabilis Lindl.

Authors:  Md Mozammel Haque; Sufia Begum; Md Hossain Sohrab; Monira Ahsan; Choudhury M Hasan; Nuruddin Ahmed; Rashedul Haque
Journal:  Pharmacogn Mag       Date:  2013-01       Impact factor: 1.085

9.  Exploring the ligand-protein networks in traditional chinese medicine: current databases, methods, and applications.

Authors:  Mingzhu Zhao; Qiang Zhou; Wanghao Ma; Dong-Qing Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-02       Impact factor: 2.629

10.  Predictive analyses of biological effects of natural products: from plant extracts to biomolecular laboratory and computer modeling.

Authors:  Roberto Gambari
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.